FIMECS, Inc.



Japanese

FIMECS, Inc.

コンテンツに移動
  • Home
  • About Us
    • Corporate Infomation
    • Leadership
  • Research
    • Technology
    • Publications
    • Pipeline
  • News
  • Recruit
  • Contact Us
  • Access
  • - Drugging Undruggable Targets -
  • - Drugging Undruggable Targets -
  • - Drugging Undruggable Targets -
  • - Drugging Undruggable Targets -
  • - Drugging Undruggable Targets -
TOP  >  Research

Research

Technology

Pipeline

Publications

Sitemap

  • Pipeline
  • About Us
    • Corporate Infomation
    • Leadership
  • Research
    • Technology
    • Publications
  • Recruit
    • Vice President, Business Development
    • Principal Scientist, Biology
    • Principal Scientist, Chemistry
    • Scientist II, Chemistry
    • Scientist I, Chemistry
    • 研究員, ケミストリー
    • Chemistry, Researcher
    • 研究員, ケミストリー
    • Manager, Intellectual Property Office
  • Access

Recent News

  • FIMECS Announces Change of Directors 2022-03-29
  • FIMECS Announces Strategic Research Collaboration with Astellas to Discover Protein Degraders Against Multiple Targets 2022-02-01
  • FIMECS Announces 1,175 Million JPY (ca. 10.3 Million USD) Series B Financing to Advance its Protein Degrader Pipeline and Platform 2022-01-24
  • FIMECS was Awarded The Global Health Innovative Technology Fund 2021-11-09
  • FIMECS Organizes Scientific Advisory Board 2021-09-13

Contact Us

Tel: +81-466-96-0261
Mail: info@fimecs.com

Copyrights: since 2018, FIMECS, Inc. All rights reserved.